nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Rifampicin—leprosy	0.795	1	CbGbCtD
Penicillamine—Drug-induced lupus erythematosus—Dapsone—leprosy	0.0882	0.43	CcSEcCtD
Penicillamine—Lupus-like syndrome—Dapsone—leprosy	0.0179	0.0874	CcSEcCtD
Penicillamine—Nephrotic syndrome—Dapsone—leprosy	0.00873	0.0426	CcSEcCtD
Penicillamine—Leukaemia—Thalidomide—leprosy	0.00802	0.0391	CcSEcCtD
Penicillamine—Proteinuria—Dapsone—leprosy	0.0048	0.0234	CcSEcCtD
Penicillamine—Protein urine present—Dapsone—leprosy	0.00474	0.0231	CcSEcCtD
Penicillamine—Interstitial lung disease—Thalidomide—leprosy	0.00305	0.0149	CcSEcCtD
Penicillamine—Cholestasis—Thalidomide—leprosy	0.00284	0.0139	CcSEcCtD
Penicillamine—Muscular weakness—Dapsone—leprosy	0.0027	0.0132	CcSEcCtD
Penicillamine—Pancreatitis—Dapsone—leprosy	0.0026	0.0127	CcSEcCtD
Penicillamine—Proteinuria—Thalidomide—leprosy	0.00246	0.012	CcSEcCtD
Penicillamine—Protein urine present—Thalidomide—leprosy	0.00242	0.0118	CcSEcCtD
Penicillamine—Neuropathy peripheral—Dapsone—leprosy	0.00231	0.0113	CcSEcCtD
Penicillamine—Leukocytosis—Thalidomide—leprosy	0.0023	0.0112	CcSEcCtD
Penicillamine—Neuropathy—Thalidomide—leprosy	0.00203	0.0099	CcSEcCtD
Penicillamine—Aplastic anaemia—Thalidomide—leprosy	0.00203	0.0099	CcSEcCtD
Penicillamine—Tinnitus—Dapsone—leprosy	0.00198	0.00964	CcSEcCtD
Penicillamine—Lymphadenopathy—Thalidomide—leprosy	0.00184	0.00897	CcSEcCtD
Penicillamine—Thrombophlebitis—Thalidomide—leprosy	0.00181	0.00884	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0018	0.0088	CcSEcCtD
Penicillamine—Injury—Thalidomide—leprosy	0.00171	0.00832	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Thalidomide—leprosy	0.00166	0.00811	CcSEcCtD
Penicillamine—Hypoglycaemia—Thalidomide—leprosy	0.00161	0.00784	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00141	0.00689	CcSEcCtD
Penicillamine—Muscular weakness—Thalidomide—leprosy	0.00138	0.00675	CcSEcCtD
Penicillamine—Eosinophilia—Thalidomide—leprosy	0.00134	0.00655	CcSEcCtD
Penicillamine—Pancreatitis—Thalidomide—leprosy	0.00133	0.00648	CcSEcCtD
Penicillamine—Pancytopenia—Thalidomide—leprosy	0.00129	0.00628	CcSEcCtD
Penicillamine—Body temperature increased—Dapsone—leprosy	0.00119	0.00581	CcSEcCtD
Penicillamine—Renal failure—Thalidomide—leprosy	0.00119	0.0058	CcSEcCtD
Penicillamine—Neuropathy peripheral—Thalidomide—leprosy	0.00118	0.00578	CcSEcCtD
Penicillamine—Stomatitis—Thalidomide—leprosy	0.00118	0.00575	CcSEcCtD
Penicillamine—Haematuria—Thalidomide—leprosy	0.00115	0.00562	CcSEcCtD
Penicillamine—Agranulocytosis—Thalidomide—leprosy	0.00113	0.0055	CcSEcCtD
Penicillamine—Urinary tract disorder—Thalidomide—leprosy	0.00107	0.00523	CcSEcCtD
Penicillamine—Urethral disorder—Thalidomide—leprosy	0.00106	0.00519	CcSEcCtD
Penicillamine—Tinnitus—Thalidomide—leprosy	0.00101	0.00493	CcSEcCtD
Penicillamine—Angiopathy—Thalidomide—leprosy	0.000984	0.0048	CcSEcCtD
Penicillamine—Alopecia—Thalidomide—leprosy	0.000959	0.00468	CcSEcCtD
Penicillamine—Vomiting—Dapsone—leprosy	0.000957	0.00467	CcSEcCtD
Penicillamine—Mental disorder—Thalidomide—leprosy	0.000951	0.00464	CcSEcCtD
Penicillamine—Dysgeusia—Thalidomide—leprosy	0.000925	0.00451	CcSEcCtD
Penicillamine—Nausea—Dapsone—leprosy	0.000894	0.00436	CcSEcCtD
Penicillamine—Anaemia—Thalidomide—leprosy	0.000873	0.00426	CcSEcCtD
Penicillamine—Agitation—Thalidomide—leprosy	0.000868	0.00423	CcSEcCtD
Penicillamine—Leukopenia—Thalidomide—leprosy	0.000845	0.00412	CcSEcCtD
Penicillamine—Arthralgia—Thalidomide—leprosy	0.000804	0.00392	CcSEcCtD
Penicillamine—Anxiety—Thalidomide—leprosy	0.000801	0.00391	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000799	0.0039	CcSEcCtD
Penicillamine—Thrombocytopenia—Thalidomide—leprosy	0.000755	0.00368	CcSEcCtD
Penicillamine—Skin disorder—Thalidomide—leprosy	0.000749	0.00365	CcSEcCtD
Penicillamine—Anorexia—Thalidomide—leprosy	0.000735	0.00358	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000702	0.00343	CcSEcCtD
Penicillamine—Decreased appetite—Thalidomide—leprosy	0.00067	0.00327	CcSEcCtD
Penicillamine—Urticaria—Thalidomide—leprosy	0.000612	0.00299	CcSEcCtD
Penicillamine—Body temperature increased—Thalidomide—leprosy	0.000609	0.00297	CcSEcCtD
Penicillamine—Hypersensitivity—Thalidomide—leprosy	0.000568	0.00277	CcSEcCtD
Penicillamine—Diarrhoea—Thalidomide—leprosy	0.000527	0.00257	CcSEcCtD
Penicillamine—Vomiting—Thalidomide—leprosy	0.00049	0.00239	CcSEcCtD
Penicillamine—Rash—Thalidomide—leprosy	0.000486	0.00237	CcSEcCtD
Penicillamine—Dermatitis—Thalidomide—leprosy	0.000486	0.00237	CcSEcCtD
Penicillamine—Nausea—Thalidomide—leprosy	0.000458	0.00223	CcSEcCtD
